Structure and catalytic function of sphingosine kinases: Analysis by site-directed mutagenesis and enzyme kinetics

被引:8
|
作者
Baker, Daniel L. [1 ]
Pham, Truc Chi T. [1 ]
Sparks, Melanie A. [1 ]
机构
[1] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
基金
美国国家科学基金会;
关键词
Sphingosine kinase; Sphingosine; 1-phosphate; Mutagenesis; Enzyme kinetics; Activity assay; TANDEM MASS-SPECTROMETRY; MOLECULAR-CLONING; DIACYLGLYCEROL KINASES; BIOLOGICAL SAMPLES; BINDING SITE; MEDIATED PHOSPHORYLATION; 1-PHOSPHATE; INHIBITORS; ASSAY; SPHINGOSINE-1-PHOSPHATE;
D O I
10.1016/j.bbalip.2012.09.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine kinases 1 and 2 (SK1 and SK2) generate the bioactive lipid mediator sphingosine 1-phosphate and as such play a significant role in cell fate and in human health and disease. Despite significant interest in and examination of the role played by SK enzymes in disease, comparatively little is currently known about the three-dimensional structure and catalytic mechanisms of these enzymes. To date, limited numbers of studies have used site directed mutagenesis and activity determinations to examine the roles of individual SK residues in substrate, calmodulin, and membrane binding, as well as activation via phosphorylation. Assays are currently available that allow for both single and bisubstrate kinetic analysis of mutant proteins that show normal, lowered and enhanced activity as compared to wild type controls. Additional studies will be required to build on this foundation to completely understand SK mediated substrate binding and phosphoryl group transfer. A deeper understanding of the SK catalytic mechanism, as well as SK interactions with potential small molecule inhibitors will be invaluable to the future design and identification of SK activity modulators as research tools and potential therapeutics. This article is part of a Special Issue entitled Advances in Lysophospholipid Research. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 50 条
  • [1] Structure and function analysis of Polygonatum cyrtonema lectin by site-directed mutagenesis
    Chen, Yuyu
    Lu, Kaimin
    Li, Jianzong
    Liang, Danfeng
    Luo, Hao
    Wang, Xiaoyun
    Wang, Xin
    Bao, Jinku
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2017, 49 (12) : 1099 - 1111
  • [2] SITE-DIRECTED MUTAGENESIS OF A CATALYTIC ANTIBODY
    STEWART, JD
    ROBERTS, VA
    CROWDER, MW
    GETZOFF, ED
    BENKOVIC, SJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 182 - 182
  • [3] ANALYSIS OF PROTEASE STRUCTURE-FUNCTION VIA SITE-DIRECTED MUTAGENESIS
    CRAIK, C
    GARDELL, S
    ROCZNIAK, S
    GRAF, L
    RUTTER, WJ
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1754 - 1754
  • [4] Structure-function analysis of human triacylglycerol hydrolase by site-directed mutagenesis: Identification of the catalytic triad and a glycosylation site
    Alam, M
    Vance, DE
    Lehner, R
    BIOCHEMISTRY, 2002, 41 (21) : 6679 - 6687
  • [5] STRUCTURE-FUNCTION ANALYSIS OF HUMAN TISSUE FACTOR BY SITE-DIRECTED MUTAGENESIS
    REHEMTULLA, A
    MILES, D
    RUF, W
    EDGINGTON, T
    ARTERIOSCLEROSIS, 1990, 10 (05): : A889 - A890
  • [6] STRUCTURE-FUNCTION ANALYSIS OF HUMAN TISSUE FACTOR BY SITE-DIRECTED MUTAGENESIS
    REHEMTULLA, A
    MILES, D
    RUF, W
    EDGINGTON, T
    CIRCULATION, 1990, 82 (04) : 132 - 132
  • [7] YEAST PHOSPHOGLYCERATE KINASE - INVESTIGATION OF CATALYTIC FUNCTION BY SITE-DIRECTED MUTAGENESIS
    WILSON, CAB
    HARDMAN, N
    FOTHERGILLGILMORE, LA
    GAMBLIN, SJ
    WATSON, HC
    BIOCHEMICAL JOURNAL, 1987, 241 (02) : 609 - 614
  • [8] MODULATION OF ENZYME SPECIFICITY BY SITE-DIRECTED MUTAGENESIS
    HEDSTROM, L
    GRAF, L
    STEWART, CB
    RUTTER, WJ
    PHILLIPS, MA
    METHODS IN ENZYMOLOGY, 1991, 202 : 671 - 687
  • [9] GENERATION OF A CATALYTIC ANTIBODY BY SITE-DIRECTED MUTAGENESIS
    BALDWIN, E
    SCHULTZ, PG
    SCIENCE, 1989, 245 (4922) : 1104 - 1107
  • [10] Structure and function of prostanoid receptors as revealed by site-directed mutagenesis
    Tai, HH
    Huang, CF
    Chiang, N
    EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY 3, 1997, 407 : 205 - 209